Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Recio F, Scalise CB, Loar P, Lumish M, Berman T, Peddada A, Kalashnikova E, Rivero-Hinojosa S, Beisch T, Nicosia B, Farmer T, Dutta P, Malhotra M, ElNaggar AC, Liu MC, Vaccarello L, Holloway RW.
Recio F, et al.
Gynecol Oncol. 2024 Mar;182:63-69. doi: 10.1016/j.ygyno.2023.12.025. Epub 2024 Jan 22.
Gynecol Oncol. 2024.
PMID: 38262240
Free article.